• Home
  • Search Results

Search Results

Young Adult (18-34)
2346 studies match your search
Open

Drug that may help Cutaneous Lupus Erythematosus

Do you have Cutaneous Lupus Erythematosus (CLE)? If you have tried antimalarials but they haven't helped your skin get better, you may be able to take part in a research study. In this study, we want to find out if a new drug improves the skin of patients with CLE. Compensation provided.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Bones, Joints, Muscles
  • Chronic Conditions
  • Skin, Hair, and Nails
Not currently enrolling

Gender and Autism Project

The goal of this study is to create a support group and resources for adolescents who identify as both autistic and gender diverse using input from adolescents, parents, and professionals.

Age & Gender
  • 10 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Child and Teen Health
  • LGBTQIA+
  • Mental and Emotional Health
  • Parents of Children
Visit Location
100% Remote (online, phone, text)
Open

An Open-label, Multicenter Study of LOXO-435 in Advanced Solid Tumor Malignancies with FGFR3 Alterations

Have you been diagnosed with cancer and either your cancer did not respond to treatment or your cancer progressed? If so, you may be able to take part in a research study evaluating the safety of an investigational treatment called LOXO-435 in cancer patients.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Bladder, Other Cancers)
Open

Nutrition for Precision Health - Tailored Nutrition Study

Nutrition is not one-size-fits-all. Nutrition, or the foods we eat, can help prevent and fight conditions such as high blood pressure, diabetes, stroke, and more. However, we all live in different environments, we come from different cultures, and each of us is starting from a different place with our health. Additionally, everyone breaks down food differently. Join the Nutrition for Precision Health research study to help researchers learn how our genes, cultural backgrounds, and environments affect our bodies' responses to food. Compensation provided.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Healthy Volunteer or General Population
Open

ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer

Do you have endometrial cancer? ]. If so, you may be able to take part in a research study looking at the safety of giving a combination treatment of the drugs ONC201 plus Atezolizumab to patients with endometrial cancer.

Age & Gender
  • 18 years ~ 99 years
  • Female
Study Interest
  • Cancer (Uterine (endometrial))
Not currently enrolling

Extensive Stage Small Cell Lung Cancer Study

The purpose of this study is to learn more about how an investigational drug (tarlatamab) works in people with extensive-stage small cell lung cancer. In this study, we want to learn more about its safety and tolerability (effects good or bad) when used in combination with one of two other drugs (atezolizumab or durvalumab). We also want to learn more about the combination of the study drug with either atezolizumab or durvalumab and carboplatin and etopopside.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Lung, Phase 1 Trials (all cancers))
Open

Chronic Disease Study

We are looking for people who are between the ages of 30-70 to join a national health study to help us better understand the impact of chronic health conditions on people living with HIV. Both people living with HIV and people without HIV are invited to take part.

Age & Gender
  • 30 years ~ 70 years
  • Male, Female, Gender Inclusive
Study Interest
  • Aging
  • Healthy Volunteer or General Population
  • LGBTQIA+
  • and 7 more
Not currently enrolling

mHealth apps for Smoking Cessation Focus Groups

To determine optimal content and design features of mHealth apps for smoking cessation that are most preferred by Black and African American adults who smoke or use other tobacco products.

Age & Gender
  • 21 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Minority Health
  • Opinions and Perceptions
  • Substance Use (tobacco, alcohol, opioids, etc)
  • Wellness and Lifestyle
Visit Location
100% Remote (online, phone, text)
Open

HER2-positive breast cancer (ADEPT)

Have you been diagnosed with HER2 positive (HER2+) breast cancer and have recently or plan to undergo surgery? If so, you may be able to take part in a research study looking at the safety of giving two drugs trastuzumab and pertuzumab in combination with hormonal therapy after surgery for your breast cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Breast)
Not currently enrolling

REHEARSE Self-Care Study

My team and I have designed an educational website to be used by men and women who have had a recent heart attack. Our goal is for participants who join the study to use the information provided to learn how to improve their self-care to help prevent another heart attack. In order to know whether our educational program is helpful, we are looking for men and women like yourself to try using and give us feedback about it.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Heart and Circulation
Visit Location
100% Remote (online, phone, text)
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research